ConductScience.org, home

Trial · NCT03759639

Results by group26

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Clinical Impression of Change in Severity (CI-CS) [Fields et al 2021]Parent Study0.86Standard Deviation 2.52score on a scale
Key Secondary Endpoint: Individual Components of the CI-CSParent StudyTreatment with IB10010.48Standard Deviation 1.34score on a scale
Key Secondary Endpoint: Individual Components of the CI-CSParent StudyPost-Treatment Washout-0.38Standard Deviation 1.45score on a scale
Key Secondary Endpoint: Change in Severity Based on Average CI-SParent Study0.08Standard Deviation 1.12score on a scale
Key Secondary Endpoint: CI-CS Score Reclassified on a 3-Point ScaleParent Study:Treatment with IB1001 / -1 (Worsened)9Participants
Key Secondary Endpoint: CI-CS Score Reclassified on a 3-Point ScaleParent Study:Treatment with IB1001 / 0 (No observable Change)3Participants
Key Secondary Endpoint: CI-CS Score Reclassified on a 3-Point ScaleParent Study:Treatment with IB1001 / +1 (Improved)20Participants
Key Secondary Endpoint: CI-CS Score Reclassified on a 3-Point ScaleParent Study:Post-treatment washout / -1 (Worsened)16Participants
Key Secondary Endpoint: CI-CS Score Reclassified on a 3-Point ScaleParent Study:Post-treatment washout / 0 (No observable Change)2Participants
Key Secondary Endpoint: CI-CS Score Reclassified on a 3-Point ScaleParent Study:Post-treatment washout / +1 (Improved)10Participants
Key Secondary Endpoint: CI-CS Score for the Non-Primary Anchor TestParent Study:Treatment with IB1001-0.20Standard Deviation 1.41score on a scale
Key Secondary Endpoint: CI-CS Score for the Non-Primary Anchor TestParent Study:Post-treatment washout0.15Standard Deviation 1.40score on a scale
Spinocerebellar Ataxia Functional Index (SCAFI) [Schmitz-Hübsch et al, 2008]Parent Study:Treatment with IB10010.0995Standard Deviation 0.3058Z-scores
Spinocerebellar Ataxia Functional Index (SCAFI) [Schmitz-Hübsch et al, 2008]Parent Study:Post-treatment washout0.0076Standard Deviation 0.3584Z-scores
Scale for Assessment and Rating of Ataxia (SARA) Score [Schmitz-Hübsch et al, 2006; Subramony, 2007]Parent Study:Treatment with IB1001-1.19Standard Deviation 2.02score on a scale
Scale for Assessment and Rating of Ataxia (SARA) Score [Schmitz-Hübsch et al, 2006; Subramony, 2007]Parent Study:Post-treatment washout1.45Standard Deviation 2.56score on a scale
EuroQuol- 5 Dimension (EQ-5D) Quality of Life Scale: Visual Analogue Scale (VAS)Parent Study:Treatment with IB100172.7Standard Deviation 19.3score on a scale
EuroQuol- 5 Dimension (EQ-5D) Quality of Life Scale: Visual Analogue Scale (VAS)Parent Study:Post-Treatment Washout68.5Standard Deviation 17.7score on a scale
Modified Disability Rating Scale (mDRS) [Iturriaga et al. 2006]Parent Study:Treatment with IB1001-0.012Standard Deviation 0.050units on a scale
Modified Disability Rating Scale (mDRS) [Iturriaga et al. 2006]Parent Study:Post-Treatment Washout0.016Standard Deviation 0.051units on a scale

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03759639/results